Prospective predictors of return to work in the 5 years after hematopoietic cell transplantation.

Journal of Cancer Survivorship : Research and Practice
Anne C KirchhoffK L Syrjala

Abstract

Work return is an indicator of recovery and functional status for cancer survivors. We investigated whether demographic, medical and functional factors predicted full-time work return following hematopoietic cell transplantation (HCT). Adults (N = 197), most with hematologic malignancy, completed assessments before their HCT and at intervals over 5 years. Assessments included treatment and demographic factors, and date of return to full-time work. We created binary variables, indicative of major impairment, from the Short Form 36 Health Survey (SF-36) mental (MCS) and physical (PCS) function component scores, dichotomized at 1 SD below population norms ( <or= 40 vs. >40). PCS and MCS were imputed for 16% of the sample. Predictors of work return were analyzed using Cox proportional hazards regression. Of the 130 patients working full-time at pre-HCT, 88 (68%) were alive and relapse-free at 5 years. Of these, 53 (60%) had returned to full-time and 28 (32%) to part-time work. For the primary analyses at 6 month post-HCT, 14 patients had already died or relapsed and 10 had returned to work. Among the remaining 106 patients, those with PCS >40 returned to work faster (Hazard Ratio (HR) 2.38, 95% Confidence Interval (CI) 1.26-4.49). ...Continue Reading

References

Jan 15, 1991·Annals of Internal Medicine·J R WingardS Piantadosi
Apr 16, 1999·Statistics in Medicine·S van BuurenD L Knook
Jan 3, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S J LeeJ C Weeks
Feb 27, 2001·Blood·G B Vogelsang
Mar 12, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M HenselA D Ho
Mar 29, 2002·Psycho-oncology·Evelien R SpeltenJos H A M Verbeek
Jul 12, 2002·Psycho-oncology·Cathy J Bradley, Heather L Bednarek
Oct 31, 2002·Statistics in Medicine·Melania Pintilie
Apr 30, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Stephanie J LeeMary E D Flowers
Jun 19, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Stephanie J LeeJane C Weeks
Aug 22, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mary E D FlowersGeorgia Vogelsang
Sep 10, 2003·Blood·Mary E D FlowersGeorgia Vogelsang
Mar 26, 2004·Transplantation Proceedings·W J Hogan, R Storb
May 20, 2004·JAMA : the Journal of the American Medical Association·Karen L SyrjalaPaul J Martin
Feb 9, 2005·Cancer·Pamela Farley ShortKaan Tunceli
Sep 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karen L SyrjalaPaul J Martin
Mar 22, 2006·Annals of Internal Medicine·Tanyalak ParimonJason W Chien
Nov 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pamela Farley Short, Mary M Vargo
Jan 19, 2008·Statistics in Medicine·Angela M WoodPatrick Royston
Feb 20, 2009·JAMA : the Journal of the American Medical Association·Angela G E M de BoerJos H A M Verbeek
May 16, 2009·Cancer Nursing·John P GarofaloJill Gjerde

❮ Previous
Next ❯

Citations

Oct 11, 2012·Cancer Nursing·Julia A GoodwinCarol Beth Stewart
Aug 21, 2013·Journal of Cancer Survivorship : Research and Practice·Trine Allerslev HorsboelAnnette de Thurah
Jan 3, 2013·European Journal of Cancer Care·P van MuijenA J van der Beek
Jun 12, 2013·European Journal of Cancer Care·E J M Pearson, V J Twigg
Nov 28, 2013·Clinical Journal of Oncology Nursing·Sandra KurtinJacy Spong
Dec 28, 2010·Oncology Nursing Forum·Kathleen Doyle LyonsTim A Ahles
May 26, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Eleshia J MorrisonDennis A Gastineau
Nov 8, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Minoo BattiwallaNavneet S Majhail
Oct 28, 2017·Journal of Cancer Survivorship : Research and Practice·M D J WolversA G E M De Boer
Mar 13, 2014·Bone Marrow Transplantation·J WinterlingK Alexanderson
Aug 8, 2017·Bone Marrow Transplantation·J MohammedS K Hashmi
Aug 2, 2019·Disability and Rehabilitation·Maurizio A TrippoliniIan D Cameron
Jun 14, 2014·The Journal of the Acoustical Society of America·Michaela WarneckeJames A Simmons
Dec 19, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Noha SharafeldinSmita Bhatia
Jan 10, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Salene M W JonesKaren L Syrjala
Aug 16, 2017·Annals of Hematology·Osai SamadiShabbir M H Alibhai
Aug 24, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Jumin ParkMargaret F Bevans
Dec 29, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·S PersoonS J Tamminga
Jan 21, 2021·Journal of Psychosocial Oncology·Lisa BriceIan Kerridge
May 4, 2020·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Rachel B SalitKaren L Syrjala
Apr 26, 2021·Transplantation and Cellular Therapy·Neel S BhattBronwen Shaw
Aug 19, 2021·Bone Marrow Transplantation·Miquel GranellUNKNOWN Group for the Study of Myeloma and Amyloidosis of Catalonia (GEMMAC)
Aug 28, 2021·Journal of Cancer Survivorship : Research and Practice·Saiko KurosawaTakahiro Fukuda
Dec 1, 2018·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Rajshekhar ChakrabortyNavneet S Majhail
Dec 11, 2021·Hematology·David Buchbinder, Nandita Khera

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.